PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells

References

• Sandru A, Voinea S, Panaitescu E, Blidaru A. Survival rates of patients with metastatic malignant melanoma. J Med Life. 2014;7(4):572. PMID:25713625.
   PubMedGoogle Scholar
• Shellenberger R, Nabhan M, Kakaraparthi S. Melanoma screening: A plan for improving early detection. Annals Med. 2016;48(3):142–8. doi:10.3109/07853890.2016.1145795.
   PubMed Web of Science ®Google Scholar
• Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol. 2007;25(12):1606–20. doi:10.1200/JCO.2006.06.0442. PMID:17443002.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681–96. doi:10.1016/j.cell.2015.05.044. PMID:26091043.
   PubMed Web of Science ®Google Scholar
• Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116(6):855–67. doi:10.1016/S0092-8674(04)00215-6. PMID:15035987.
   PubMed Web of Science ®Google Scholar
• Fedorenko IV, Gibney GT, Sondak VK, Smalley KSM. Beyond BRAF: where next for melanoma therapy & quest. Br J Cancer. 2015;112(2):217–26. doi:10.1038/bjc.2014.476. PMID:25180764.
   PubMed Web of Science ®Google Scholar
• Lopez‐Bergami P. The role of mitogen‐and stress‐activated protein kinase pathways in melanoma. Pigment Cell Melanoma Res. 2011;24(5):902–21. doi:10.1111/j.1755-148X.2011.00908.x. PMID:21914141.
   PubMed Web of Science ®Google Scholar
• Lazova R, Klump V, Pawelek J. Autophagy in cutaneous malignant melanoma. J Cutaneous Pathol. 2010;37(2):256–68. doi:10.1111/j.1600-0560.2009.01359.x.
   PubMed Web of Science ®Google Scholar
• Corazzari M, Fimia GM, Lovat P, Piacentini M. Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications. Semin Cancer Biol. 2013;23:337–43. Academic Press. doi:10.1016/j.semcancer.2013.07.001. PMID:23856558.
   PubMed Web of Science ®Google Scholar
• Fimia GM, Piacentini M. Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci. 2010;67(10):1581–8. doi:10.1007/s00018-010-0284-z. PMID:20165902.
   PubMed Web of Science ®Google Scholar
• Croft A, Tay KH, Boyd SC, Guo ST, Jiang CC, Lai F, Tseng HY, Jin L, Rizos H, Hersey P, et al. Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress. J Invest Dermatol. 2014;134(2):488–97. doi:10.1038/jid.2013.325. PMID:23921951.
   PubMed Web of Science ®Google Scholar
• Schönthal AH. Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica. 2012;2012:85751. doi:10.6064/2012/857516.
   Google Scholar
• Sykes EK, Mactier S, Christopherson RI. Melanoma and the unfolded protein response. Cancers. 2016;8(3):30. doi:10.3390/cancers8030030.
   Web of Science ®Google Scholar
• Corazzari M, Lovat PE, Armstrong JL, Fimia GM, Hill DS, Birch-Machin M, Redfern CPF, Piacentini M. Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007;96(7):1062–71. doi:10.1038/sj.bjc.6603672. PMID:17353921.
   PubMed Web of Science ®Google Scholar
• Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, Brown AM, Piacentini M, Birch-Machin M, Redfern CP. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res. 2008;68(13):5363–9. doi:10.1158/0008-5472.CAN-08-0035. PMID:18593938.
   PubMed Web of Science ®Google Scholar
• Corazzari M. ER stress & autophagy in cancer: contenders or partners in crime. Int J Mol Biol Biochem. 2013;1:23–28.
   Google Scholar
• Corazzari M, Gagliardi M, Fimia GM, Piacentini M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 2017;7:78. doi:10.3389/fonc.2017.00078. PMID:28491820.
   PubMed Web of Science ®Google Scholar
• Corazzari M, Rapino F, Ciccosanti F, Giglio P, Antonioli M, Conti B, Fimia GM, Lovat PE, Piacentini M. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma. Cell Death Differentiation. 2015;22(6):946–58. doi:10.1038/cdd.2014.183.
   PubMed Web of Science ®Google Scholar
• Giglio P, Fimia GM, Lovat PE, Piacentini M, Corazzari M. Fateful music from a talented orchestra with a wicked conductor: Connection between oncogenic BRAF, ER stress, and autophagy in human melanoma. Mol Cell Oncol. 2015;2(3):e995016. doi:10.4161/23723556.2014.995016. PMID:27308477.
   PubMed Web of Science ®Google Scholar
• Sullivan RJ, Flaherty KT. Resistance to BRAF-targeted therapy in melanoma. Eur J Cancer. 2013;49(6):1297–304. doi:10.1016/j.ejca.2012.11.019. PMID:23290787.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annual Rev Immunol. 2013;31:51–72. doi:10.1146/annurev-immunol-032712-100008.
   PubMed Web of Science ®Google Scholar
• Garg AD, Dudek-Peric AM, Romano E, Agostinis P. Immunogenic cell death. Int J Dev Biol. 2015;59(1-2-3):131–40. doi:10.1387/ijdb.150061pa. PMID:26374534.
   PubMed Web of Science ®Google Scholar
• Bezu L, Gomes-de-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Combinatorial strategies for the induction of immunogenic cell death. Frontiers Immunol. 2015;6:275.
   PubMed Web of Science ®Google Scholar
• Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, et al. Molecular and translational Classifications of DaMPs in immunogenic cell death. Frontiers Immunol. 2015;6:588. doi:10.3389/fimmu.2015.00588.
   PubMed Web of Science ®Google Scholar
• Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget. 2014;5(14):5190–1. doi:10.18632/oncotarget.2266. PMID:25114034.
   PubMedGoogle Scholar
• Dudek AM, Garg AD, Krysko DV, De Ruysscher D, Agostinis P. Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev. 2013;24(4):319–33. doi:10.1016/j.cytogfr.2013.01.005. PMID:23391812.
   PubMed Web of Science ®Google Scholar
• Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, Séror C, Métivier D, Perfettini JL, Zitvogel L, et al. Chemotherapy induces ATP release from tumor cells. Cell Cycle. 2009;8(22):3723–8. doi:10.4161/cc.8.22.10026. PMID:19855167.
   PubMed Web of Science ®Google Scholar
• Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, Métivier D, Galluzzi L, Perfettini JL, et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differentiation. 2014;21(1):79–91. doi:10.1038/cdd.2013.75. PMID:23852373.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2016;12(1):1–222. doi:10.1080/15548627.2015.1100356. PMID:26799652.
   PubMed Web of Science ®Google Scholar
• Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, Wang H. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Exp Rev Clin Immunol. 2014;10(6):713–27. doi:10.1586/1744666X.2014.909730.
   PubMed Web of Science ®Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050–9. doi:10.1038/nm1622. PMID:17704786.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Sarkar A, Walle LV, Vitari AC, Amer AO, Wewers MD, Tracey KJ, Kanneganti TD, Dixit VM. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol. 2010;185(7):4385–92. doi:10.4049/jimmunol.1000803. PMID:20802146.
   PubMed Web of Science ®Google Scholar
• Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundbäck P, Valdes-Ferrer SI, Olofsson PS, Kalb T, Roth J, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488(7413):670–4. doi:10.1038/nature11290. PMID:22801494.
   PubMed Web of Science ®Google Scholar
• Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J. 2010;24(3):665–83. doi:10.1096/fj.09-145482. PMID:19940256.
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54–61. doi:10.1038/nm1523. PMID:17187072.
   PubMed Web of Science ®Google Scholar
• Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differentiation. 2008;15(9):1499–509. doi:10.1038/cdd.2008.67. PMID:18464797.
   PubMed Web of Science ®Google Scholar
• Hertzog PJ. Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses. Immunol Cell Biol. 2012;90(5):471–3. doi:10.1038/icb.2012.15. PMID:22648073.
   PubMed Web of Science ®Google Scholar
• Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014;20(11):1301–9. doi:10.1038/nm.3708. PMID:25344738.
   PubMed Web of Science ®Google Scholar
• Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, et al. Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 2009;28(5):578–90. doi:10.1038/emboj.2009.1. PMID:19165151.
   PubMed Web of Science ®Google Scholar
• Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqué A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L. eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars Cancer Biol. 2015;33:86–92. Academic Press. doi:10.1016/j.semcancer.2015.02.004.
   PubMed Web of Science ®Google Scholar
• Donnelly N, Gorman AM, Gupta S, Samali A. The eIF2α kinases: their structures and functions. Cell Mol Life Sci. 2013;70(19):3493–511. doi:10.1007/s00018-012-1252-6. PMID:23354059.
   PubMed Web of Science ®Google Scholar
• Couturier J, Morel M, Pontcharraud R, Gontier V, Fauconneau B, Paccalin M, Page G. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid β (Aβ)-treated cells and in APPSLPS1 knock-in mice. J Biol Chem. 2010;285(2):1272–82. doi:10.1074/jbc.M109.041954. PMID:19889624.
   PubMed Web of Science ®Google Scholar
• Reid DW, Tay AS, Sundaram JR, Lee IC, Chen Q, George SE, Nicchitta CV, Shenolikar S. Complementary roles of GADD34-and CReP-containing eukaryotic initiation factor 2α phosphatases during the unfolded protein response. Mol Cell Biol. 2016;36(13):1868–80. doi:10.1128/MCB.00190-16. PMID:27161320.
   PubMed Web of Science ®Google Scholar
• Kepp O, Galluzzi L, Giordanetto F, Tesniere A, Vitale I, Martins I, Schlemmer F, Adjemian S, Zitvogel L, Kroemer G. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle. 2009;8(23):3971–7. doi:10.4161/cc.8.23.10191. PMID:19901557.
   PubMed Web of Science ®Google Scholar
• Dalet A, Argüello RJ, Combes A, Spinelli L, Jaeger S, Fallet M, Vu Manh TP, Mendes A, Perego J, Reverendo M, et al. Protein synthesis inhibition and GADD34 control IFN‐β heterogeneous expression in response to dsRNA. EMBO J. 2017;36(6):761–82. doi:10.15252/embj.201695000. PMID:28100675.
   PubMed Web of Science ®Google Scholar
• Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, Yuan J. A selective inhibitor of eIF2α dephosphorylation protects cells from ER stress. Science. 2005;207:935–39. doi:10.1126/science.1101902.
   Google Scholar
• Tsaytler P, Harding HP, Ron D, Bertolotti A. Selective Inhibition of a Regulatory Subunit of Protein Phosphatase 1 Restores Proteostasis. Science. 2011;332:91–94. doi:10.1126/science.1201396. PMID:21385720.
   PubMed Web of Science ®Google Scholar
• Papaioannou NE, Beniata OV, Vitsos P, Tsitsilonis O, Samara P. Harnessing the immune system to improve cancer therapy. Annals Translational Med. 2016;4(14):261. doi:10.21037/atm.2016.04.01.
   PubMed Web of Science ®Google Scholar
• Choy MS, Yusoff P, Lee IC, Newton JC, Goh CW, Page R, Shenolikar S, Peti W. Structural and Functional Analysis of the GADD34:PP1 eIF2alpha Phosphatase. Cell Rep. 2015;11(12):1885–91. doi:10.1016/j.celrep.2015.05.043. PMID:26095357.
   PubMed Web of Science ®Google Scholar
• Pagliarini V, Giglio P, Bernardoni P, De Zio D, Fimia GM, Piacentini M, Corazzari M. Downregulation of E2F1 during ER stress is required to induce apoptosis. J Cell Sci. 2015;128(6):1166–79. doi:10.1242/jcs.164103. PMID:25616897.
   PubMed Web of Science ®Google Scholar
• Antunes F, Corazzari M, Pereira G, Fimia GM, Piacentini M, Smaili S. Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death. Biochem Biophys Res Commun. 2017;485(1):16–22. doi:10.1016/j.bbrc.2016.09.149. PMID:27693581.
   PubMed Web of Science ®Google Scholar
• Pagliarini V, Wirawan E, Romagnoli A, Ciccosanti F, Lisi G, Lippens S, Cecconi F, Fimia GM, Vandenabeele P, Corazzari M, et al. Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response. Cell Death Differentiation. 2012;19(9):1495–504. doi:10.1038/cdd.2012.27. PMID:22441670.
   PubMed Web of Science ®Google Scholar
• Corazzari M, Lovat PE, Armstrong JL, Fimia GM, Hill DS, Birch-Machin M, Redfern CPF, Piacentini M. Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007;96(7):1062–71. doi:10.1038/sj.bjc.6603672. PMID:17353921.
   PubMed Web of Science ®Google Scholar
• Armstrong JL, Corazzari M, Martin S, Pagliarini V, Falasca L, Hill DS, Ellis N, Al Sabah S, Redfern CPF, Fimia GM, et al. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clin Cancer Res. 2011;17(8):2216–26. doi:10.1158/1078-0432.CCR-10-3003. PMID:21270111.
   PubMed Web of Science ®Google Scholar
• Ciccosanti F, Corazzari M, Soldani F, Matarrese P, Pagliarini V, Iadevaia V, Tinari A, Zaccarelli M, Perfettini JL, Malorni W, et al. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients. Antivir Ther. 2010;15(3):377–90. doi:10.3851/IMP1530. PMID:20516557.
   PubMed Web of Science ®Google Scholar